The Breast
Volume 19, Issue 3 , Pages 180-187 , June 2010

The less than whole breast radiotherapy approach

  • Margot Lehman

      Affiliations

    • Southern Zone Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia
    • Corresponding Author InformationCorresponding author.
    • ,
  • Brigid Hickey

      Affiliations

    • Southern Zone Radiation Oncology, Mater Centre, Brisbane, Australia

References 

  1. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham D, Cronin W, et al. Re-analysis and results after 12 years of follow-up in a randomised clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333(22):1456–1461
  2. Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, et al. Breast conservation is a safe method in patients with a small cancer of the breast. Long-term results of three randomised trial on 1973 patients. Eur J Cancer. 1995;31(10):1574–1579
  3. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomised trials. New Engl J Med. 1995;333(22):1444–1455
  4. Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomised trial comparing breast-conserving therapy with mastectomy: European organisation for research and treatment of cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143–1150
  5. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med. 2002;347(16):1233–1241
  6. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomised study comparing breast conserving surgery with radical mastectomy for early breast cancer. New Engl J Med. 2002;347(16):1227–1232
  7. Holland R, Veling SH, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trial of breast-conserving surgery. Cancer. 1985;56(5):979–990
  8. Vaidya JS, Vyas JJ, hinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996;74:820–824
  9. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview o the randomised trials. Lancet. 2005;366:2087–2106
  10. Cochrane R, Valasiadou P, Wilston , Al-Ghazal S, Macmillan R. Cosmesis and satisfaction after breast conserving surgery correlates with percentage of breast volume excised. Br J Surg. 2003;1505–1509
  11. Whelan T, Levine M, Julian J, Kirkbride P, Skingley P. The effects of radiotherapy on quality of life of women with breast cancer: results of a randomised trial. Ontario Clinical Oncology Group. Cancer. 2000;85:2260–2266
  12. Schoen AT, Brenein DA, Kelly MD, Knauss WA, Slinguff CL. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005;23(28):7074–7080
  13. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer. 1986;57:1717–1724
  14. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-Year results after sector resection with or without postoperative radiotherapy for Stage I breast cancer: a randomised trial. J Clin Oncol. 1999;17:2326–2333
  15. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch M, et al. Randomised clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88:1659–1664
  16. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomised trial. Ann Oncol. 2001;12:997–1003
  17. Malmstrom P, Holmber L, Anderson H, Mattsson J, Jonsson P, Tennvall-Nittby L, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer. 2003;39:1690–1697
  18. Smith T, Lee D, Turner A, Carter D, Haffty B. True recurrence vs. new primary ipsilateral breast tumour relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses and therapeutic management. Int J Radiation Oncology Biol Phys. 2000;48:1281–1289
  19. Vicini FA, Kestin LK, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;64(3):722–730
  20. Rosenstein B, Lymberis S, Formenti S. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys. 2004;60:1393–1404
  21. Fentiman IS, Poole C, Tong D, Winter PJ, Mayles HM, Turner P, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 1991;27:447–450
  22. Fentiman IS, Poole C, Tong D, Winter P, Gregory W, Mayles H, et al. Inadequacy of iridium implant as a sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32A:608–611
  23. Fentiman IS, Deshmane V, Tong D, Winter J, Mayles H, Chaudary M. Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol. 2004;71:281–285
  24. Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F, et al. Patterns of breast recurrence in a pilot study of brachytherapy confine to the lumpectomy site for early breast cancer with 6 years minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57:1239–1246
  25. Polgár C, Major T, Fodor J, Nemeth G, Orosz Z, Sulyok Z, et al. HDR brachytherapy alone versus whole breast radiotherapy with or without tumour bed boost after breast conserving surgery: 7-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  26. Polgár C, Major T, Lövey K, Frohlich G, Takacsi-Nagy Z, Fodor J. Hungarian experience on partial breast irradiation versus whole breast irradiation: 12-year results of a phase II trial and updated results of a randomised study (abstract). Brachytherapy. 2008;7:91–92
  27. Chen PY, Vicini FA, Benitez P, Kestin L, Wallace M, Mitchell C, et al. Longterm cosmetic results and toxicity after accelerated partial-breast irradiation – a method of radiation delivery by interstitial brachytherapy for the treatment of early stage breast carcinoma. Cancer. 2006;106:991–999
  28. Vicini FA, Antonucci V, Wallace M, Gilbert S, Goldstein N, Kestin L, et al. Longterm efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys. 2007;68:341–346
  29. Johansson B, Karlsson L, Liljegren G, Hardell L, Persliden J. Pulse dose rate brachytherapy as the sole adjuvant radiotherapy after breast conserving surgery of T1–T2 breast cancer: first longterm results from a clinical study. Radiother Oncol. 2009;90:30–35
  30. Kaufman SA, DiPetrillo TA, Price LL, Bassett Midle J, Wazer D. Longterm outcome and toxicity in a phase I/II trial using high dose rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy. 2007;6:286–292
  31. Arthur DW, Winter K, Kuske RR, Bolton J, Rabinovitch R. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumour control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008;72:467–473
  32. King TA, Bolton JS, Kuske RR, Fuhrman G, Scroggins T, Jiang X. Longterm results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg. 2000;180:299–304
  33. Ott OJ, Hildebrandt G, Pötter R, Hammer J, Lotter M, Resch A, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German–Austrian multi-centre trial. Radiother Oncol. 2007;82:281–286
  34. Patel RR, Christensen ME, Hodege C, Adkinson J, Das R. Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for National Surgical Adjuvant Breast and Bowel B-39/Radiation Therapy Oncology Group 0413 Trial: 5-year results. Int J Radiat Oncol Biol Phys. 2008;70:970–973
  35. Krishnan L, jewell WR, Tawfik OW, Krishnan E. Breast conservation therapy with tumour bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91–96
  36. Yoshida K, Nose T, Masuda N, Yamazaki H, Kotsuma T, Yoshida M, et al. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer. 2009;16(2):105–112
  37. Aristei C, Palumbo I, Cucciarelli F, Cavalli A, Tarducci R, Raymondi C, et al. Partial breast irradiation with interstitial high-dose rate brachytherapy in early breast cancer: results of a phase II prospective study. Eur J Surg Oncol. 2009;35(2):144–150
  38. Lawenda BD, Taghian AG, Kachnic LA, Hamdi H, Smith B, Gadd M, et al. Dose volume analysis of radiotherapy for T1NO invasive breast cancer treated by local excision and partial breast irradiation by low dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56:671–680
  39. Wazer D, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):889–897
  40. Patel R, Becker S, Das R, Mackie T. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimension conformal radiotherapy and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;68(3):935–942
  41. Weed D, Edmundson G, Vicini F, Chen P, Martinez A. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy. 2005;4:121–129
  42. Benitez P, Keisch M, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–462
  43. Niehoff P, Polgár C, Ostertag H, Major T, Sulyok Z, Kimmig B, et al. Clinical experience with the MammoSite® radiation therapy system for intracavitary brachytherapy of breast cancer – results from an international phase II trial. Radiother Oncol. 2006;79:316–320
  44. Nelson J, Beitsch P, Vicini F, Quiet C, Garcia D, Snider H, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg. 2009;198:83–89
  45. Chen S, Dickler A, Kirk M, Shah A, Jokich P, Solmos G, et al. Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys. 2007;69:25–31
  46. Cuttino LW, Keisch M, Jenrette JM, Dragun A, Prestidge B, Quiet C, et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early stage breast cancer: 2 year results. Int J Radiat Oncol Biol Phys. 2008;71:107–114
  47. Dragun A, Harper J, Jenrette J, Sinha D, Cole D. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single institution experience of 100 patients with 2 years of follow-up. Int J Radiat Oncol Biol Phys. 2007;68:354–358
  48. Chao KK, Vicini F, Wallace M, Mitchell C, Chen P, Ghilezan M. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: P; The William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32–40
  49. Niehoff P, Ballardini B, Polgár C, Major T, Hammer J, Richetti A, et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low risk breast cancer. Breast. 2006;15:319–325
  50. Belkacémi Y, Chauvet M, Giard S, Villette S, Lacornerie T, Bonodeau F, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol. 2009;90(1):23–29
  51. Haley M, Beriwal S, Heron D, Kim H, Falk J, Johnson R, et al. MammoSite® accelerated partial breast irradiation: a single institution outcomes analysis with 2 years of followup. Brachytherapy. 2009;8(1):9–13
  52. Zannis V, Beitsch P, Vicini F, Quiet C, Keleher A, Garcia D. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American society of breast surgeons MammoSite breast brachytherapy registry trial. Am J Surg. 2005;190:530–538
  53. Taghian AG, Kozak KR, Doppke KP, Katz A, Smith B, Gadd M. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2006;64:1092–1099
  54. Vicini F, Arthur D, Polgar C, Kuske R. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys. 2003;57:1210–1213
  55. Formenti SC, Truong MT, Goldberg JD, Mukhi V, Rosenstein B, Roses D, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60:493–504
  56. Kozak KR, Smith BL, Adams J, Kornmehl E, Katz A, Gadd M, et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66:691–698
  57. Landis DM, Luo W, Song J, Bellon J, Punglia R, Wong J. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007;67:1299–1308
  58. Vicini F, Chen P, Wallace M, Mitchell C, Hasan Y, Grills I, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69(4):1124–1130
  59. Chen P, Gustafson G, Mitchell C, Wallace M, Hasan Y, Martinez A. Three-year clinical experience utilising 3D-conformal radiation therapy to deliver accelerated partial breast irradiation (APBI) 2008. Int J Radiat Oncol Biol Phys. 2008;72:S3–S4
  60. Taghian A, Alm El-Din M, Smith B, Ancukiewicz M, MacDonald S, Katz A, et al. Interim results of a phase I/II trial of 3D-conformal external beam accelerated partial breast irradiation in patients with early breast cancer. Int J Radiat Oncol Biol Phys. 2008;72:S4
  61. Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, et al. Initial efficacy results of RTOG 0319: three dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys. 2008;72:S3
  62. Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg. 2005;242:101–106
  63. Vaidja J, Baum M, Tobias J, D'Souza , Naidu S, Morgan S, et al. Targeted intra-operative radiotherapy (TARGIT): an innovative method of treatment for early breast cancer. Ann Oncol. 2001;12:1075–1080
  64. Vaidya J, Baum M, Tobias J, Massarut S, Wenz F, Murphy O, et al. Targeted intra-operative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Radiat Oncol Biol Phys. 2006;66:1335
  65. Pignol JP, Keller B, Rakovitch E, Sankreacha R, Easton H, Que H, et al. First report of a permanent breast 103PD seed implant as adjuvant radiation treatment for early stage breast cancer. Int J Radiat Oncol Biol Phys. 2006;64(1):176–181
  66. Polgár C, Fodor J, Major T, Nemeth G, Lovey K, Orosz Z, et al. Breast conserving treatment with partial or whole breast irradiation for low-risk invasive breast cancer – 5 year results of a randomised trial. Int J Radiat Oncol Biol Phys. 2007;69(3):694–702
  67. Polgár C, Major T. Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol. 2009;14:7–24
  68. Ribeiro G, Magee B, Swindell R, Harris M, Banerjee S. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol. 1993;5:278–283
  69. Dodwell D, Dyker K, Brown K, Hawkins K, Cohen D, Stead M, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol. 2005;17:618–622
  70. Valachis A, Mauri D, Polyzos N, Mavroudis V, Georgoulias , Casazza G, et al. Partial breast irradiation or whole breast radiotherapy in early breast cancer: a meta-analysis. ProcAsco. 2009;Abstract CRA532
  71. Wolmark N, Curran WJ, Vicini F, White J, Arthur D, Kuske R, et al. On behalf of NSABP and RTOG. NSABP protocol B-39. RTOG protocol 0413. A randomised phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I or II breast cancer. Available from: Trial Protoc. March 13, 2007;1–132htpp://www.rtog.org/members/protocols/0413
  72. Ontario Clinical Oncology Group, Canadian Institutes of Health Research, Canadian Breast Cancer Research Alliance . RAPID: randomised trial of accelerated partial breast irradiation. Available from: 2008;http://www.clinicaltrials.gov/ct2/show/NCT00282035
  73. Strnad V, Polgár C. On behalf of the European Brachytherapy Breast Cancer GEC-ESTRO Working Group. Phase III multicenter trial interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in-sit of the female breast. Available from: http://www.apbi.uni-erlangen.de.
  74. Yarnold J, Coles C. On behalf of the IMPORT LOW Trial Management Group: Intensity modulated and partial organ radiotherapy. Randomised trial testing intensity modulated and partial organ radiotherapy following breast conservation surgery for early breast cancer. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00814567.
  75. Orecchia R, Ciocca M, Tosi G, Franzetti S, Luini A, Gatti G, et al. Intraoperative electron beam radiation therapy (ELIOT) to the breast. Breast. 2005;14:541–546
  76. http://www.clinicaltrials.gov/ct2/show/NCT00983684
  77. Armaroli L, Barbieri E, Bertoni F, Busutti L, Cardinali M, Cartei F, et al. Breast cancer with low risk of local recurrence: partial and accelerated radiation with three-dimensional conformal radiotherapy (3DCRT) v standard radiotherapy after conserving surgery (Phase III study). Version 01.05.2007. Available from: http://groups.eortc.be/radio/res/irma/synopsis_trial_irma 1.pdf.
  78. Smith B, Arthur D, Buchholz T, Haffty B, Hahn C, Hardenbergh P, et al. Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987–1001

PII: S0960-9776(10)00059-7

doi: 10.1016/j.breast.2010.03.005

The Breast
Volume 19, Issue 3 , Pages 180-187 , June 2010

Article Tools